VERNON W ANTHONY
SEC CIK 1369091 · EDGAR
BoughtSold
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:25 | 2026-06-03 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | A - Grant | $0.00 | +11.6K | 209.3K | +6% | $0 |
| 2026-06-03 16:52 | 2026-06-02 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | S - Sale | $15.77 | -2,945 | 197.7K | -1% | -$46.4K | |
| D | 2026-04-28 16:27 | 2026-04-28 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | M - OptEx | $11.39 | +21.5K | 200.6K | +12% | +$244.9K |
| D | 2026-02-18 | 2026-02-15 | MKC | McCormick & Company | VERNON W ANTHONY | Dir | M - OptEx | — | +2,222 | 14.0K | +19% | — |
| D | 2025-06-06 | 2025-06-04 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | A - Grant | $0.00 | +11.2K | 179.1K | +7% | $0 |
| 2025-06-04 | 2025-06-03 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | S - Sale | $17.35 | -999 | 167.9K | -0.6% | -$17.3K | |
| D | 2025-03-18 | 2025-03-15 | MKC | McCormick & Company | VERNON W ANTHONY | Dir | M - OptEx | $0.00 | +1,344 | 11.8K | +13% | $0 |
| D | 2024-06-06 | 2024-06-04 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | S - Sale | $23.89 | -964 | 164.8K | -0.6% | -$23.0K |
| D | 2024-06-06 | 2024-06-05 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | A - Grant | $0.00 | +4,053 | 169.8K | +2% | $0 |
| D | 2024-03-19 | 2024-03-15 | MKC | McCormick & Company | VERNON W ANTHONY | Dir | M - OptEx | — | +1,255 | 10.5K | +14% | — |
| D | 2023-06-09 | 2023-06-07 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Dir | A - Grant | $0.00 | +3,853 | 165.8K | +2% | $0 |
| D | 2023-03-16 | 2023-03-15 | MKC | McCormick & Company | VERNON W ANTHONY | Dir | M - OptEx | $0.00 | +1,044 | 9,227 | +13% | $0 |
| D | 2022-03-17 | 2022-03-15 | MKC | McCormick & Company | VERNON W ANTHONY | Dir | M - OptEx | — | +1,139 | 8,183 | +16% | — |
Purchase Sale Sale after option exercise All abbreviations